Forbes March 1, 2025
Bruce Japsen

A Walgreens breakup into three companies would move away from the industry trend of consolidating healthcare services.

A report last week that Walgreens parent Walgreens Boots Alliance would divide up into three businesses would involve selling or spinning off Boots UK, which has more than 1,800 stores overseas “ranging from local community pharmacies to large destination health and beauty stores,” the company’s website says.

In the U.S, Walgreens retail pharmacies would also be separated into a different company. And a third company would include the fast-growing specialty pharmacy business, which Walgreens has already been highlighting as a $24 billion enterprise.

“While the company would initially be taken private as a whole, Sycamore (Partners) plans to separate Walgreens’ three main...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Pharma, Pharma / Biotech
How AI Is Transforming The Pharmaceutical Industry
Supporting the Development of Drugs for Rare Diseases — The Importance of Regulatory Transparency
Lilly to invest over $50 billion in US manufacturing expansion
Lawmakers renew focus on PBMs: 4 things to know
How Tariffs Will Drive Up Pharmaceutical Costs & Which Drug Categories Will Be Most Affected

Share This Article